Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
fluticasone propionate + salmeterol (Arven İlaç)
- Development stage
- Phase 4
- Lead developer
- Arven İlaç
- Modality
- Small Molecules
- Administration
- Inhalation
01
Overview
Cyplos Arvohaler is a combination inhalation therapy developed by Arven Pharmaceuticals for the treatment of asthma and chronic obstructive pulmonary disease (COPD). It is delivered via a pressurized metered-dose inhaler (pMDI). The product contains two active ingredients: fluticasone propionate, a synthetic corticosteroid that acts as a glucocorticoid receptor agonist to reduce airway inflammation, and salmeterol, a long-acting beta-2 adrenergic receptor agonist (LABA) that provides prolonged bronchodilation by relaxing airway smooth muscle. This combination is designed to address both the inflammatory and bronchoconstrictive components of obstructive airway diseases.
- Brand names
- Cyplos Arvohaler
- Other names
- fluticasone propionate + salmeterolfluticasone propionate/salmeterol
02
Targets
GR (Glucocorticoid receptor)ADRB1 (β1)ADRB2 (β2)
Beyond the preview
Go deeper on fluticasone propionate + salmeterol (Arven İlaç).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on fluticasone propionate + salmeterol (Arven İlaç).